BSECompany Update6d ago · 13 Aug 2026, 06:22 pm

Monitoring Agency Report for the quarter ended on June 30, 2026

Pavna Industries Ltd · 543915

✦ AI SummaryFundraise

Pavna Industries Ltd has received a Monitoring Agency Report from CARE Ratings Limited for the quarter ended June 30, 2026, related to the Preferential Issue of Equity Shares and Fully Convertible Warrants.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Pavna Industries Ltd - 543915 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Attachments (1)

📄

e9fa855d-cafe-4022-9aa0-4b309b8854c3.pdf

pdf

Download →
View document text
PAVNA INDUSTRIES LIMITED CIN-L34109UP1994PLC016359 Registered Office: Vimlanchal, Hari Nagar, Aligarh, Uttar Pradesh – 202001 Corporate Address: Sushayat Khurd Aligarh-Agra Road, Near Mangalayatan Mandir, Sasni, Hathras, Aligarh, Uttar Pradesh, India, 204216 Email: cs@pavnagroup.com; Website: www.pavna.in Tel No.: +91-8006409332 August 13, 2026 To, To, The BSE Limited The National Stock Exchange of India Dept of Corporate Services Limited Phirozee Jeejeebhoy Towers, The Listing Department Dalal Street, Fort, Exchange Plaza, C-1, Block G, Bandra Kurla Mumbai - 400001 (Maharashtra) Complex, Bandra (East), Scrip Code :543915 Mumbai- 400051(Maharashtra) Symbol :PAVNAIND ISIN-INE07S101038 Sub: Monitoring Agency Report for the quarter ended June 30, 2026. Ref: Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (“Listing Regulations”). Dear Sir/Mam, Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (“Listing Regulations”) read with Regulation 162A of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 ,we are enclosing herewith the Monitoring Agency Report dated August 13, 2026 for the quarter ended June 30, 2026, in relation to the Preferential Issue of Equity Shares and Fully Convertible Warrants of the Company has received from Monitoring Agency, Care Ratings Limited as per Monitoring Agency Agreement dated October 4, 2024. You are requested to take the above information on record. Yours faithfully For Pavna Industries Limited Swapnil Jain Managing Director DIN-01542555 Encl: As above No. CARE/KRO/GEN/2026-27/1067 The Board of Directors Pavna Industries Limited Vimlachal Hari Nagar Aligarh Uttar Pradesh, India Pin- 202001 August 13, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Preferential Issue of Equity Share and Fully Convertible Warrants of Pavna Industries Limited (“the Company”) We write in our capacity of Monitoring Agency for the Preferential issue of equity shares and fully convertible warrants for the amount aggregating to Rs. 210.70 crore of the Company and refer to our duties cast under 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated October 04, 2024. Request you to kindly take the same on records. Thanking you, Yours faithfully, Abhishek Khemka Associate Director Abhishek.Khemka@careedge.in CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital 15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East), Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: Pavna Industries Ltd For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Refer Section 3 (b) Range of Deviation: Refer Section 3 Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Abhishek Khemka Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital 15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East), Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in CIN-L67190MH1993PLC071691 1) Issuer Details: Name of the issuer : Pavna Industries Limited Name of the promoter : Mr. Swapnil Jain & Mrs. Asha Jain Industry/sector to which it belongs : Manufacturing (Auto Ancillary) 2) Issue Details Issue Period : Jan 29, 2025 Type of issue (public/rights) : Preferential Issue Type of specified securities : Equity shares and Fully Convertible warrants IPO Grading, if any : Not Applicable Issue size (in crore) : Rs. 210.70 crore CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, 15 Park Street, Kolkata – 700016 Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-33-4018 1600/2283 1803 - 400 022 Phone: +91-22-6754 3456 • www.careedge.in CIN-L67190MH1993PLC071691 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Monitoring Agency Board of Directors preparation of report CA certificate*, Bank The utilization of the fund is according to Whether all utilization is as per the Yes statements, Management the objectives mentioned as per Board No comments disclosures in the Offer Document? certificate Resolution dated January 29, 2025. Whether shareholder approval has been obtained in case of material Not CA certificate and Nil No comments deviations# from expenditures applicable Management certificate disclosed in the Offer Document? Whether the means of finance for the CA Certificate and disclosed objects of the issue have No Nil No comments Management Certificate changed? Is there any major deviation observed As per last MA report over the earlier monitoring agency No Nil No comments (Q4FY26) reports? Whether all Government/statutory Not CA Certificate and approvals related to the object(s) have Nil No comments Management Certificate been obtained? Appliable Whether all arrangements pertaining to Not CA Certificate and technical assistance/collaboration are in Nil No comments Management Certificate operation? Appliable CARE Ratings Limited Unit N [Showing first 8,000 characters — download PDF for full document]